Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
sMVA-N/S
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
sMVA-N
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
sMVA-S/N
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
sMVA-S
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
MVC-COV1901
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/29/2020
Neobavaisoflavone
Potential treatment - theoretical effect Natural product Antiviral Nov/28/2020
(-)-beta-Sesquiphellandrene
Potential treatment - theoretical effect Natural product Antiviral Nov/27/2020
SARS-CoV-2 RBD-Fc
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/27/2020
H4
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2020
B38
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2020
Candidate vaccine (Wuhan Institute of Biological Products and Wuhan Institute of Virology)
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/26/2020
mAb 1D2
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
Atazanavir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020
Saquinavir
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020
Noscapine
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
Lomefloxacin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020
AZD0156
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
PBDNJ0803
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
URMC-099-C
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
CHEMBL3752642
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020